[211At]At-AuNP-ABDMPL16

N/A

Report date: 2025/10/20 14:18:46

Base Information

Drug Name[211At]At-AuNP-ABDMPL16

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Astatine > 211AtRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionProgrammed death-ligand 1 modulators

TargetsProgrammed death-ligand 1

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesShanghai Tenth People'S Hospital

China Registration ClassN/A

Develop Information

Active CompaniesShanghai Tenth People'S Hospital

Inactive CompaniesN/A

Active IndicationsMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A